PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study

The treatment of diseases that affect the central nervous system (CNS) represents a great research challenge due to the restriction imposed by the blood–brain barrier (BBB) to allow the passage of drugs into the brain. However, the use of modified nanomedicines engineered with different ligands that...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmaceutics
Autori principali: Hoyos-Ceballos, Gina P., Ruozi, Barbara, Ottonelli, Ilaria, Da Ros, Federica, Vandelli, Maria Angela, Forni, Flavio, Daini, Eleonora, Vilella, Antonietta, Zoli, Michele, Tosi, Giovanni, Duskey, Jason T., López-Osorio, Betty L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7023215/
https://ncbi.nlm.nih.gov/pubmed/31963430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12010072
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi